(氯甲基)三苯基碘化膦 | 68089-86-1

• 物质功能分类: 有机原料 - 有机膦化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: (氯甲基)三苯基碘化膦
• 中文别名: (氯甲基)三苯基碘化
• 英文名称: (chloromethyl)triphenylphosphonium iodide
• 英文别名: chloromethyl(triphenyl)phosphanium;iodide
• CAS: 68089-86-1
• 化学式: C₁₉H₁₇ClP*I
• 分子量: 438.675
• InChiKey: YMNRWRKDEPEIAQ-UHFFFAOYSA-M

物化性质

• 熔点：
  210°C (dec.)
• 稳定性/保质期：
  远离氧化物、光和水分/潮湿。

计算性质

• 辛醇/水分配系数(LogP)：
  1.18
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险类别码：
  R36/37/38
• 安全说明：
  S26,S36
• 储存条件：
  存放在密封容器中，并置于阴凉、干燥处。需远离氧化剂，避免接触湿气和水源，务必避光保存。

反应信息

• 作为反应物：
  描述：

  (氯甲基)三苯基碘化膦 以 乙二醇二甲醚 、 N,N-二甲基甲酰胺 为溶剂， 反应 7.0h， 生成 triphenylphosphorane
  参考文献：
  名称：

  (.alpha.-Haloalkyl)phosphonium salts and sulfur nucleophiles: a new type of reaction mechanism

  摘要：

  DOI：

  10.1021/jo00233a008
• 作为产物：
  描述：

  (氯甲基)三苯基氯化磷 在 碘甲烷 作用下， 以63%的产率得到(氯甲基)三苯基碘化膦
  参考文献：
  名称：

  Kukhar', V. P.; Pasternak, V. I.; Shevchenko, I. V., Journal of Organic Chemistry USSR (English Translation), 1981, p. 161 - 166

  摘要：

  DOI：

文献信息

• Smenamide A Analogues. Synthesis and Biological Activity on Multiple Myeloma Cells
  作者：Alessia Caso、Ilaria Laurenzana、Daniela Lamorte、Stefania Trino、Germana Esposito、Vincenzo Piccialli、Valeria Costantino

  DOI：10.3390/md16060206

  日期：——

  Smenamides are an intriguing class of peptide/polyketide molecules of marine origin showing antiproliferative activity against lung cancer Calu-1 cells at nanomolar concentrations through a clear pro-apoptotic mechanism. To probe the role of the activity-determining structural features, the 16-epi-analogue of smenamide A and eight simplified analogues in the 16-epi series were prepared using a flexible synthetic route. The synthetic analogues were tested on multiple myeloma (MM) cell lines showing that the configuration at C-16 slightly affects the activity, since the 16-epi-derivative is still active at nanomolar concentrations. Interestingly, it was found that the truncated compound 8, mainly composed of the pyrrolinone terminus, was not active, while compound 13, essentially lacking the pyrrolinone moiety, was 1000-fold less active than the intact substance and was the most active among all the synthesized compounds.

  斯美那胺类是一类引人注目的海洋来源的肽/聚酮分子，通过明确的促凋亡机制在纳摩尔浓度下对肺癌Calu-1细胞显示出抗增殖活性。为了探究活性决定结构特征的作用，通过灵活的合成途径制备了斯美那胺A的16-表异构体以及16-表系列的八个简化类似物。合成的类似物在多发性骨髓瘤（MM）细胞系中进行了测试，结果显示C-16位构型轻微影响活性，因为16-表衍生物在纳摩尔浓度下仍然有活性。有趣的是，发现主要由吡咯啉酮末端组成的截短化合物8没有活性，而基本上缺乏吡咯啉酮部分的化合物13的活性比完整物质低1000倍，是所有合成化合物中最有活性的。
• Pharmaceutically active pyrrolidine derivatives as bax inhibitors
  申请人：——

  公开号：US20030171309A1

  公开（公告）日：2003-09-11

  The present invention is related to new substituted pyrrolidine derivatives of formula (I). Said compounds are preferably for use as pharmaceutically active compounds. Specifically, pyrrolidine derivatives of formula (I) are useful in the treatment and/or prevention of neurodegenerative disorders, diseases associated with polygultamine tracts, epilepsy, ischemia, infertility, cardiovascular disorders renal hypoxia, hepatitis and AIDS. Said pyrrolidine derivatives display a modulatory and most notably a down-regulating-up to an inhibitory-activity with respect to the cellular death agonist Bax and/or the activation pathways leading to Bax and allows therefore to block the release of cytochrome (c). The present invention is furthermore related to novel pharmaceutically activity substituted pyrrolidine derivatives as well as to methods of their preparation, wherein X is selected from the group consisting of O, S, CR<6>R<7>, NOR<6>, NNR<6>R<7>; A is selected from the group consisting of —(C═O)—, —(C═O)—O—, —C(═NH)—, —(C═O)—NH—, —(C═S)—NH, —SO2-, —SO2NH—; —CH2-; B is either a group —(C═O)—NR<8>R<9> or represents a heterocyclic residue having the formula (II) wherein Q is NR<10>, O or S; n is an integer selected of 0, 1 or 2; Y, Z and E form together with the 2 carbons to which they are attached a 5-6 membered aryl or heteroaryl ring.

  本发明涉及新的取代吡咯烷衍生物的化学式(I)。所述化合物通常用作药用活性化合物。具体来说，化学式(I)的吡咯烷衍生物在治疗和/或预防神经退行性疾病、与多谷氨酸氨基酸序列相关的疾病、癫痫、缺血、不孕症、心血管疾病、肾脏缺氧、肝炎和艾滋病方面具有用处。所述吡咯烷衍生物显示出对细胞死亡促进子Bax和/或导致Bax激活途径的调节作用，最显著地是下调至抑制活性，并因此允许阻止细胞色素(c)的释放。本发明还涉及新的具有药用活性的取代吡咯烷衍生物，以及它们的制备方法，其中X选自O、S、CR<6>R<7>、NOR<6>、NNR<6>R<7>组成的群；A选自—(C═O)—、—(C═O)—O—、—C(═NH)—、—(C═O)—NH—、—(C═S)—NH、—SO2-、—SO2NH—；—CH2-；B是一个群—(C═O)—NR<8>R<9>或代表具有化学式(II)的杂环残基，其中Q是NR<10>、O或S；n是选自0、1或2的整数；Y、Z和E与它们连接的两个碳共同形成一个5-6成员芳香族或杂芳族环。
• In Search of Simplicity and Flexibility: A Rational Access to Twelve Fluoroindolecarboxylic Acids
  作者：Manfred Schlosser、Assunta Ginanneschi、Frédéric Leroux

  DOI：10.1002/ejoc.200600118

  日期：2006.7

  a basicity gradient-driven selective migration of the heavy halogen. An unexpected finding on the way to the target compds. were the rigorously site-selective metalation of the 5-fluoro-N-(trialkylsilyl)indole (exclusive deprotonation of the 4-position). The fluoroindoles, although previously known, were accessed more conveniently from suitably substituted nitrobenzenes using the Bartoli or the Leimgruber-Batcho

  所有十二个在苯并环上带有氟取代基和羧基的吲哚羧酸已经被制备出来。直接来自相应的氟吲哚或氯化衍生物。通过氢/金属置换（“金属化”），或通过卤素/金属置换从溴或碘氟吲哚中提取，有机金属中间体每次都被二氧化碳捕获。在大多数情况下，尽管不是所有情况，五元环中的氮原子必须由三烷基甲硅烷基保护。一些溴或碘氟吲哚成功地经受了重卤素的碱性梯度驱动的选择性迁移。在通往目标化合物的途中意外发现。是 5-氟-N-（三烷基甲硅烷基）吲哚的严格位点选择性金属化（4-位的独家去质子化）。氟吲哚虽然以前是已知的，但可以使用 Bartoli 或 Leimgruber-Batcho 方法从适当取代的硝基苯中更方便地获得。精心设计了一种新的非常有吸引力的吲哚合成，包括 N-酰基保护的苯胺的邻位锂化，然后是邻位甲酰化、Wittig 氯亚甲基化和碱催化环化，并伴有脱氯化氢。这五个连续的步骤可以简化为一个方便的一锅协议。[在 SciFinder
• Photochemical Generation of Highly Destabilized Vinyl Cations:  The Effects of α- and β-Trifluoromethyl versus α- and β-Methyl Substituents
  作者：Kaj van Alem、Geerte Belder、Gerrit Lodder、Han Zuilhof

  DOI：10.1021/jo0487956

  日期：2005.1.1

  primarily generated α-CH3 and α-CF3 vinyl cations, or from the α-CH3 vinyl cation formed from the β-CH3 vinyl cation via a 1,2-phenyl shift. The β-CF3 vinyl cation reacts with methanol yielding nucleophilic substitution products, no migration of the phenyl ring producing the α-CF3 vinyl cation occurs. The α-CF3 vinyl cation, which is the most destabilized vinyl cation generated thus far, gives a 1,2-fluorine

  在乙烯基卤化物的甲醇光化学反应1 - 4，具有在α-或β位上具有甲基或三氟甲基的取代基的卤代苯乙烯，已定量研究。除E / Z异构化外，反应还包括乙烯基自由基的形成，从而导致还原性脱卤化产物，以及乙烯基阳离子的形成，从而导致消除，亲核取代和重排产物。乙烯基阳离子是紧密的离子对的一部分，其中卤化物作为抗衡离子。消除产品均来自主要产生α-CHβ-质子损失的结果3和α-CF 3个乙烯基阳离子，或来自α-CH 3从β-CH形成乙烯基的阳离子3经由1,2-苯基移乙烯基阳离子。β型CF 3用甲醇得到的亲核取代产物乙烯基阳离子反应，没有苯环产生α-CF迁移3乙烯基阳离子发生。α-CF 3乙烯基阳离子，这是迄今为止所产生的最不稳定的乙烯基阳离子，则提供与质子损失在竞争1,2-氟移。乙烯基的阳离子稳定化的实验得出的顺序在该研究中光生的α-CF 3 <β-CF 3 <β-CH 3 <α-CH 3，通过量子化学计算，提供的溶剂的效果证实被取入帐户。
• Pharmaceutically active pyrrolidine derivatives
  申请人：——

  公开号：US20030212012A1

  公开（公告）日：2003-11-13

  The present invention is related to pyrrolidine derivatives of formula (I). Said 1 compounds are preferably for use as pharmaceutically active compounds. Specifically, pyrrolidine derivatives of formula (I) are useful in the treatment and/or prevention of premature labor, premature birth and dysmenorrhea. In particular, the present invention is related to pyrrolidine derivatives displaying a substantial modulatory, notably an antagonist activity of the oxytocin receptor. More preferably, said compounds are useful in the treatment and/or prevention of disease states mediated by oxytocin, including premature labor, premature birth and dysmenorrhea. The present invention is furthermore related to novel pyrrolidine derivatives as well as to methods of their preparation, wherein X is selected from the group consisting of CR6R7, NOR6, NNR6R7; A is selected from the group consisting of —(C═O)—, —(C═O)—O—, —C(═NH)—, —(C═O)—NH—, —(C═S)—NH, —SO22—, —SO2NH—, —CH2—,B is either a group —(C═O)—NR8R9 or represents a heterocyclic residue having the formula (a) wherein Q is NR10, O or S; n is an integer selected of 0, 1 or 2; Y, Z and E form together with the 2 carbons to which they are attached a 5-6 membered aryl or heteroaryl ring.

  本发明涉及式(I)的吡咯烷衍生物。所述化合物优选用作药用活性化合物。具体而言，式(I)的吡咯烷衍生物在治疗和/或预防早产、早产和痛经方面是有用的。特别是，本发明涉及显示出氧催产素受体显著调节作用，特别是拮抗剂活性的吡咯烷衍生物。更具体地，所述化合物在治疗和/或预防由氧催产素介导的疾病状态，包括早产、早产和痛经方面是有用的。本发明还涉及新型吡咯烷衍生物以及其制备方法，其中X从CR6R7、NOR6、NNR6R7组中选择；A从—(C═O)—、—(C═O)—O—、—C(═NH)—、—(C═O)—NH—、—(C═S)—NH、—SO22—、—SO2NH—、—CH2—中选择；B是一个群—(C═O)—NR8R9或表示具有式(a)的杂环残基，其中Q是NR10、O或S；n是选择的整数0、1或2；Y、Z和E与它们连接的2个碳一起形成一个5-6成员芳基或杂芳基环。